convulex 300 mg gastroresistentne pehmekapsel
g.l. pharma gmbh - valproehape - gastroresistentne pehmekapsel - 300mg 100tk
cevaxel süstelahuse pulber ja lahusti
ceva sante animale - tseftiofuur - süstelahuse pulber ja lahusti - 50mg 1ml 1g 1tk; 50mg 1ml 4g 1tk
glucose baxter 10% infusioonilahus
baxter healthcare limited - süsivesikud - infusioonilahus - 100mg 1ml 250ml 30tk; 100mg 1ml 250ml 1tk; 100mg 1ml 1000ml 10tk; 100mg 1ml 500ml 1tk; 100mg 1ml 500ml 20tk; 100mg 1ml 1000ml 1tk; 100mg 1ml 250ml 36tk
vaxzevria (previously covid-19 vaccine astrazeneca)
astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaktsiinid - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
kolisin neo süsteemulsioon
bioveta a.s. - escherichia coli - süsteemulsioon - 1rtÜ 1annus 50annus 12tk; 1rtÜ 1annus 25annus 12tk; 1rtÜ 1annus 125annus 20tk; 1rtÜ 1annus 10annus 10tk; 1rtÜ 1annus 50annus 20tk; 1rtÜ 1annus 250annus 1tk; 1rtÜ 1annus 25annus 1tk; 1rtÜ 1annus 5annus 1tk; 1rtÜ 1annus 5annus 10tk; 1rtÜ 1annus 250annus 20tk
herzass-ratiopharm 100mg tablett
ratiopharm gmbh - atsetüülsalitsüülhape - tablett - 100mg 50tk
colecalciferol fresenius suukaudsed tilgad, lahus
fresenius kabi polska sp. z o.o. - kolekaltsiferool - suukaudsed tilgad, lahus - 14400rÜ 1ml 12.5ml 1tk
depakine chrono 500 mg toimeainet prolongeeritult vabastav tablett
sanofi winthrop industrie - valproehape - toimeainet prolongeeritult vabastav tablett - 500mg 30tk
depakine chrono 300 mg toimeainet prolongeeritult vabastav tablett
sanofi winthrop industrie - valproehape - toimeainet prolongeeritult vabastav tablett - 300mg 100tk
nordimet
nordic group b.v. - metotreksaadi - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastilised ained - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.